Patents by Inventor Jack William Schultz

Jack William Schultz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150374681
    Abstract: A montelukast composition having a therapeutically effective amount of montelukast in a sustained release is disclosed. A montelukast composition having a therapeutically effective amount of montelukast in an immediate release and sustained release is also disclosed.
    Type: Application
    Filed: September 3, 2015
    Publication date: December 31, 2015
    Inventor: Jack William Schultz
  • Patent number: 9149472
    Abstract: A montelukast composition having a therapeutically effective amount of montelukast in a sustained release is disclosed. A montelukast composition having a therapeutically effective amount of montelukast in an immediate release and sustained release is also disclosed.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: October 6, 2015
    Inventor: Jack William Schultz
  • Publication number: 20140065231
    Abstract: A montelukast composition having a therapeutically effective amount of montelukast in a sustained release is disclosed. A montelukast composition having a therapeutically effective amount of montelukast in an immediate release and sustained release is also disclosed.
    Type: Application
    Filed: November 4, 2013
    Publication date: March 6, 2014
    Inventor: Jack William Schultz
  • Publication number: 20140045884
    Abstract: Methods for the treatment of cognitive, emotional and mental ailments using therapeutically effective amounts of compositions including leukotriene receptor antagonists, leukotriene synthesis inhibitors or leukotriene modifiers, zafirlukasts, montelukasts, other members of the family—lukasts, zileutons.
    Type: Application
    Filed: October 18, 2013
    Publication date: February 13, 2014
    Inventor: Jack William Schultz
  • Patent number: 8575194
    Abstract: Methods for the treatment of cognitive, emotional and mental ailments using therapeutically effective amounts of compositions including leukotriene receptor antagonists, leukotriene synthesis inhibitors or leukotriene modifiers, zafirlukasts, montelukasts, other members of the family -lukasts, zileutons.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: November 5, 2013
    Inventor: Jack William Schultz